公司資料
Materialise 股價、新聞與催化劑
- 股票代碼:
- MTLS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Belgium
股票表現
6.73 USD (-2.75%)
收盤價
最後更新: 2026年8月17日
401M USD
市值
股價為何變動
As of Aug 17, 2026, MTLS closed down 2.75% at $6.73. No new same-company headline was identified in the current news window.
公司概覽
Additive-Manufacturing Technology
Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models.
Medical Solutions
The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other 3D-printed devices used by clinicians and medical-device companies.
Manufacturing Software
Materialise sells software used to prepare, manage and optimize additive-manufacturing workflows across industrial and healthcare customers.
Production Services
The company also manufactures prototypes and end-use parts for customers that require additive-manufacturing capacity without operating their own production infrastructure.
未來催化劑
- Materialise's catalysts are 3D-printing adoption, orthopedic software, and medical-application demand. The company benefits when clinical and industrial demand both stay healthy.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。